American journal of kidney diseases : the official journal of the National Kidney Foundation
-
Randomized Controlled Trial Multicenter Study Comparative Study
Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
To compare the safety and efficacy of the traditional Chinese medicine Shenqi particle and standard therapy with prednisone and cyclophosphamide (control) in adult patients with idiopathic membranous nephropathy (IMN). ⋯ Shenqi particle may be a promising alternative therapy for adults with IMN and nephrotic syndrome.
-
Randomized Controlled Trial Comparative Study
Earlier-start versus usual-start dialysis in patients with community-acquired acute kidney injury: a randomized controlled trial.
Optimum timing of the initiation of dialysis therapy in acute kidney injury is not clear. ⋯ Our data do not support the earlier initiation of dialysis therapy in community-acquired acute kidney injury.